Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

Chloroquinoxaline Sulfonamide in Treating Patients With Stage IV Colorectal Cancer

Study:

A Phase II Study of Chloroquinoxaline Sulfonamide (CQS) in Colorectal Cancer Stage IV

Rationale:

Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.

Purpose:

Phase II trial to study the effectiveness of chloroquinoxaline sulfonamide in treating patients who have stage IV colorectal cancer.

Study Status: Completed

Recruiting:
n/a

Condition Intervention Phase
Colorectal Cancer Drug: chloroquinoxaline sulfonamide Phase 2

Verified by Ohio State University Comprehensive Cancer Center September, 2002

Sponsored by: Ohio State University Comprehensive Cancer Center
Information provided by: National Cancer Institute
ClinicalTrials.gov identifier: NCT00005864

Study Type: Interventional

Study Design: Primary Purpose: Treatment

Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio 44195
United States

Eric H. Kraut, MD., Study Chair

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.

Cleveland Clinic Mobile Site